Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mol Reprod Dev ; 84(10): 1076-1085, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28688214

RESUMO

Pregnancy in mammals requires remodeling of the uterus to become receptive to the implanting embryo. Remarkably similar morphological changes to the uterine epithelium occur in both eutherian and marsupial mammals, irrespective of placental type. Nevertheless, molecular differences in uterine remodeling indicate that the marsupial uterus employs maternal defences, including molecular reinforcement of the uterine epithelium, to regulate embryonic invasion. Non-invasive (epitheliochorial) embryonic attachment in marsupials likely evolved secondarily from invasive attachment, so uterine defences in these species may prevent embryonic invasion. We tested this hypothesis by identifying localization patterns of Talin, a key basal anchoring molecule, in the uterine epithelium during pregnancy in the tammar wallaby (Macropus eugenii; Macropodidae) and the brush tail possum (Trichosurus vulpecula; Phalangeridae). Embryonic attachment is non-invasive in both species, yet Talin undergoes a clear distributional change during pregnancy in M. eugenii, including recruitment to the base of the uterine epithelium just before attachment, that closely resembles that of invasive implantation in the marsupial species Sminthopsis crassicaudata. Basal localization occurs throughout pregnancy in T. vulpecula, although, as for M. eugenii, this pattern is most specific prior to attachment. Such molecular reinforcement of the uterine epithelium for non-invasive embryonic attachment in marsupials supports the hypothesis that less-invasive and non-invasive embryonic attachment in marsupials may have evolved via accrual of maternal defences. Recruitment of basal molecules, including Talin, to the uterine epithelium may have played a key role in this transition.


Assuntos
Implantação do Embrião/fisiologia , Macropodidae/fisiologia , Prenhez , Trichosurus/fisiologia , Útero/metabolismo , Animais , Células Epiteliais/metabolismo , Feminino , Macropodidae/metabolismo , Phalangeridae/metabolismo , Phalangeridae/fisiologia , Gravidez , Ratos , Talina/metabolismo , Trichosurus/metabolismo , Trofoblastos/metabolismo , Útero/citologia , Útero/fisiologia
2.
J Vet Pharmacol Ther ; 38(5): 482-7, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-25622984

RESUMO

[Correction added on 23 March 2015, after first online publication: Terminal half-life values of enrofloxacin is corrected in the fourth sentence of the abstract] Clinically healthy common ringtail possums (n = 5) received single doses of 10 mg/kg enrofloxacin orally and then 2 weeks later subcutaneously. Serial plasma samples were collected over 24 h for each treatment phase, and enrofloxacin concentrations were determined using a validated HPLC assay. Pharmacokinetic parameters were determined by noncompartmental analysis. Following oral administration, plasma concentrations were of therapeutic relevance (Cmax median 5.45 µg/mL, range 2.98-6.9 µg/mL), with terminal-phase half-life (t½ ) shorter than in other species (median 3.09 h, range 1.79-5.30 h). In contrast, subcutaneous administration of enrofloxacin did not achieve effective plasma concentrations, with plasma concentrations too erratic to fit the noncompartmental model except in one animal. On the basis of the AUC:MIC, enrofloxacin administered at 10 mg/kg orally, but not subcutaneously, is likely to be effective against a range of bacterial species that have been reported in common ringtail possums.


Assuntos
Antibacterianos/farmacocinética , Fluoroquinolonas/farmacocinética , Phalangeridae/metabolismo , Administração Oral , Animais , Antibacterianos/administração & dosagem , Antibacterianos/sangue , Cromatografia Líquida de Alta Pressão/veterinária , Ciprofloxacina/sangue , Enrofloxacina , Feminino , Fluoroquinolonas/administração & dosagem , Fluoroquinolonas/sangue , Injeções Subcutâneas/veterinária , Masculino , Phalangeridae/sangue
3.
Vet Immunol Immunopathol ; 107(3-4): 189-99, 2005 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-15993492

RESUMO

Bovine and possum macrophages were infected in vitro with a virulent strain of Mycobacterium bovis, and mycobacterial replication was measured in the infected macrophages cultured under a variety of conditions. Virulent M. bovis replicated substantially in alveolar possum macrophages as well as in bovine blood monocyte-derived macrophages. Addition of recombinant bovine interferon-gamma (IFN-gamma) with low concentrations of lipopolysaccharide (LPS) rendered bovine macrophages significantly more resistant to M. bovis replication. Disruption of iron levels in infected macrophages by addition of apotransferrin or bovine lactoferrin blocked replication of M. bovis in both bovine and possum macrophages. On the other hand, addition of exogenous iron, either in the form of iron citrate or iron-saturated transferrin, rendered macrophages of both species much more permissive for the replication of M. bovis. The impact of iron deprivation/loading on the mycobacteriostatic activity of cells was independent of nitric-oxide release, as well as independent of the generation of oxygen radical species in both possum and bovine macrophages. Exogenous iron was shown to reverse the ability of IFN-gamma/LPS pulsed bovine macrophages to restrict M. bovis replication. When autologous possum lymphocytes from animals vaccinated with M. bovis strain BCG were added to infected macrophages, they rendered the macrophages less permissive for virulent M. bovis replication. Loading the cells with iron prior to this macrophage-lymphocyte interaction, reversed this immune effect induced by sensitized cells. We conclude that, in two important animal species, intracellular iron level plays an important role in M. bovis replication in macrophages, irrespective of their activation status.


Assuntos
Bovinos/imunologia , Ferro/metabolismo , Macrófagos/metabolismo , Macrófagos/microbiologia , Mycobacterium bovis/patogenicidade , Phalangeridae/imunologia , Animais , Bovinos/metabolismo , Bovinos/microbiologia , Divisão Celular/efeitos dos fármacos , Técnicas In Vitro , Ferro/farmacologia , Linfocinas/metabolismo , Ativação de Macrófagos , Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Mycobacterium bovis/efeitos dos fármacos , Phalangeridae/metabolismo , Phalangeridae/microbiologia , Especificidade da Espécie , Virulência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...